Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk

被引：0

作者：

Frumm, Stacey M. ^{[1
]}

Kim, Haesook T. ^{[2
]}

Kelkar, Amar H. ^{[3
]}

Ho, Vincent T. ^{[4
]}

Gooptu, Mahasweta ^{[3
]}

Gibson, Christopher James ^{[3
]}

Koreth, John ^{[3
]}

Shapiro, Roman M. ^{[3
]}

Romee, Rizwan ^{[3
]}

Nikiforow, Sarah ^{[3
]}

Antin, Joseph H. ^{[5
]}

Soiffer, Robert J. ^{[3
]}

Rolles, Benjamin ^{[6
]}

Shimony, Shai ^{[7
]}

Bewersdorf, Jan Philipp ^{[8
]}

Kewan, Tariq ^{[9
]}

Alhajahjeh, Abdulrahman ^{[10
]}

Luskin, Marlise R. ^{[4
]}

Garcia, Jacqueline S. ^{[7
]}

Chen, Evan C. ^{[3
]}

Lane, Andrew A. ^{[11
]}

Wadleigh, Martha ^{[3
]}

Winer, Eric S. ^{[3
]}

Stone, Richard M. ^{[3
]}

DeAngelo, Daniel J. ^{[3
]}

Zeidan, Amer M. ^{[12
]}

Lindsley, Coleman ^{[3
]}

Cutler, Corey ^{[3
]}

Stahl, Maximilian ^{[4
]}

机构：

[1] Brigham & Womens Hosp, Brookline, MA USA

[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA

[3] Dana Farber Canc Inst, Boston, MA USA

[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[5] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA USA

[6] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA USA

[7] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[8] Mem Sloan Kettering Canc Ctr, New York, NY USA

[9] Yale Univ, Dept Internal Med, Sect Hematol, New Haven, CT USA

[10] Univ Jordan, Amman, Jordan

[11] Dana Farber Canc Inst Inc, Dept Med Oncol, Boston, MA USA

[12] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol,Yale Canc Ctr, New Haven, CT USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-185220

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
Della Porta, M. G.
Jackson, C. H.
Alessandrino, E. P.
Rossi, M.
Bacigalupo, A.
van Lint, M. T.
Bernardi, M.
Allione, B.
Bosi, A.
Guidi, S.
Santini, V.
Malcovati, L.
Ubezio, M.
Milanesi, C.
Todisco, E.
Voso, M. T.
Musto, P.
Onida, F.
Iori, A. P.
Cerretti, R.
Grillo, G.
Molteni, A.
Pioltelli, P.
Borin, L.
Angelucci, E.
Oldani, E.
Sica, S.
Pascutto, C.
Ferretti, V.
Santoro, A.
Bonifazi, F.
Cazzola, M.
Rambaldi, A.
LEUKEMIA, 2017, 31 (11) : 2449 - 2457
[22] Utility Of Revised International Prognostic Scoring System (R-IPSS) To Predict Outcome Of Myelodysplastic Syndromes (MDS) Patients After Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Corrales-Yepez, Maria Gabriela
Field, Teresa
List, Alan
Anasetti, Claudio
Perkins, Janelle
Al Ali, Najla H.
Mishra, Asmita
Padron, Eric
Lancet, Jeffrey E.
Kharfan-Dabaja, Mohamed A.
Komrokji, Rami S.
BLOOD, 2013, 122 (21)
[23] Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Were Treated with Hypomethylating Agents (HMA)
Kewan, Tariq
Bewersdorf, Jan Philipp
Blaha, Ondrej
Stahl, Maximilian
Ali, Najla Hal
DeZern, Amy E.
Sekeres, Mikkael A.
Carraway, Hetty E.
Desai, Pinkal
Griffiths, Elizabeth A.
Stein, Eytan M.
Brunner, Andrew M.
Amaya, Maria L.
Zeidner, Joshua F.
Savona, Michael R.
Stempel, Jessica M.
Chandhok, Namrata Sonia
Logothetis, Constantine
Ramaswamy, Rahul
Rose, Ameera
Roboz, Gail J.
Rolles, Benjamin
Wang, Eunice S.
Harris, Amyah C.
Shallis, Rory M.
Xie, Zhuoer
Padron, Eric
Maciejewski, Jaroslaw P.
Sallman, David A.
Della Porta, Matteo Giovanni
Komrokji, Rami S.
Zeidan, Amer M.
BLOOD, 2023, 142
[24] Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System
Arnan, Montserrat
Pomares, Helena
Sanchez-Ortega, Isabel
Alonso, Ester
Condom, Maria
Encuentra, Maite
Grau, Javier
Sureda, Anna
BLOOD, 2016, 128 (22)
[25] Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Underwent Allogenic Stem Cell Transplantation (HSCT)
Kewan, Tariq
Bewersdorf, Jan Philipp
Blaha, Ondrej
Stahl, Maximilian
Al Ali, Najla H.
DeZern, Amy E.
Sekeres, Mikkael A.
Uy, Geoffrey L.
Carraway, Hetty E.
Desai, Pinkal
Griffiths, Elizabeth A.
Stein, Eytan M.
Brunner, Andrew M.
Amaya, Maria L.
Zeidner, Joshua F.
Savona, Michael R.
Stempel, Jessica M.
Chandhok, Namrata Sonia
Logothetis, Constantine
Cochran, Hunter
Rose, Ameera
Roboz, Gail J.
Wang, Eunice S.
Rolles, Benjamin
Harris, Amyah C.
Shallis, Rory M.
Xie, Zhuoer
Padron, Eric
Maciejewski, Jaroslaw P.
Sallman, David A.
Della Porta, Matteo Giovanni
Komrokji, Rami S.
Zeidan, Amer M.
BLOOD, 2023, 142
[26] Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT
Robin, Marie
Raphael, Porcher
van Biezen, Anja
Volin, Liisa
Mufti, Ghulam J.
Craddock, Charles
Finke, Jurgen
Espiga, Carlos Richard
Passweg, Jakob
Peniket, Andrew
Maertens, Johan
Sucak, Gulsan
Gedde-Dahl, Tobias
Vitek, Antonin
Nagler, Arnon
Blaise, Didier
Beelen, Dietrich
Maillard, Natacha
Schwerdtfeger, Rainer
Iacobelli, Simona
de Witte, Theo
Kroeger, Nicolaus
BLOOD, 2014, 124 (21)
[27] The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant
Ana Alarcon Tomas
Karissa Whiting
Molly Maloy
Josel D. Ruiz
Sean Devlin
Miriam Sanchez-Escamilla
Lucrecia Yañez
Nerea Castillo
Martina Pennisi
Christina Cho
Brian Shaffer
Hugo Castro-Malaspina
Virginia Klimek
Sergio A. Giralt
Roni Tamari
Miguel-Angel Perales
Bone Marrow Transplantation, 2021, 56 : 2749 - 2754
[28] The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant
Tomas, Ana Alarcon
Whiting, Karissa
Maloy, Molly
Ruiz, Josel D.
Devlin, Sean
Sanchez-Escamilla, Miriam
Yanez, Lucrecia
Castillo, Nerea
Pennisi, Martina
Cho, Christina
Shaffer, Brian
Castro-Malaspina, Hugo
Klimek, Virginia
Giralt, Sergio A.
Tamari, Roni
Perales, Miguel-Angel
BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2749 - 2754
[29] Decision Analysis of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome Stratified According to the Revised International Prognostic Scoring System (IPSS-R)
Della Porta, Matteo Giovanni
Alessandrino, Emilio Paolo
Jackson, Christopher H.
Pascutto, Cristiana
Bacigalupo, Andrea
Malcovati, Luca
Van Lint, Maria Teresa
Allione, Bernardino
Bernardi, Massimo
Onida, Francesco
Guidi, Stefano
Iori, Anna Paola
Cerretti, Raffaella
Marenco, Paola
Pioltelli, Pietro
Angelucci, Emanuele
Bosi, Alberto
Cazzola, Mario
Rambaldi, Alessandro
BLOOD, 2014, 124 (21)
[30] Prognostic Impact of Variant Allelic Frequency of Molecular Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) on Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes
Hamilton, Betty Ky
Majhail, Navneet S.
Hirsch, Cassandra
Przychodzen, Bartolmiej
Rybicki, Lisa
Kalaycio, Matt E.
Bolwell, Brian
Gerds, Aaron
Sobecks, Ronald M.
Hanna, Rabi
Sekeres, Mikkael
Maciejewski, Jaroslaw
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S71 - S71

← 1 2 3 4 5 →